Responsible Business & Sustainability
Our Strategy
Our Responsible Business & Sustainability (RB&S) initiatives are built into our corporate strategy, helping us meet key business goals. They ensure operational resilience through sustainable practices and boost profitability by developing medicines in a more cost-effective way. By fostering an inclusive culture, we attract and keep top talent, bringing fresh ideas and driving innovation. RB&S is at the core of everything we do and centers on four focus areas: Advancing Global Health, Empowering Our Colleagues, Innovating Sustainably, and Operating Responsibly. To support our goal, we have aligned our strategy with the United Nations Global Compact and have been a signatory since 2022.
“As a leading global oncology company with an ongoing mission to being a good corporate citizen, we know we must continue to do right not only by our patients, colleagues, and stakeholders, but also the communities in which we operate.”
John V. Oyler
Co-Founder, Chairman and CEO
Advancing Global Health
Goal
Bring multiple high quality new molecules from discovery into the clinic on an annual basis.
2025 Progress
In 2025, five new molecules entered the clinic, demonstrating the strength and scalability of our discovery engine.
Goal
Push forward new approvals for our medicines and expand access for underserved populations.
2025 Progress
In 2025, BeOne medicines gained new approvals in 26 countries.
60+ marketing authorization applications in multiple indications are under review around the world.
The BeOne Foundation supported six programs around the world in 2025 through its second round of Access to Cancer Care grants.
Empowering Our Colleagues
Goal
Maintain colleague engagement scores globally versus 2022 engagement scores with a stretch goal of +3%.
2025 Progress
The 2025 engagement survey achieved the stretch goal with an overall engagement score of 87%, representing a 3% increase compared to the 2022 score. This improvement reflects continued progress in fostering a highly engaged workforce.
Innovating Sustainably
Goal
Reduce our Scope 1 and 2 emissions by 25% per unit of internally manufactured commercial product by 2026 (with 2021 as a base year).
2025 Progress
We achieved our GHG emissions goal to reduce our Scope 1 and 2 emissions by 25% per unit of internally manufactured commercial product by 2026 (with 2021 as the base year). This milestone was reached primarily through a strategic focus on energy conservation and efficiency improvements across operations, supplemented by the purchase of Energy Attribute Certificates.
Goal
Set a quantitative Scope 3 emissions goal by 2025.
2025 Progress
In October 2025, BeOne set a target to reduce Scope 3 emissions per unit of internally manufactured commercial product by 2030 from a 2024 baseline.
Goal
Develop a plan to better align key privacy performance metrics with Responsible Business & Sustainability practices by 2025.
2025 Progress
The Privacy & Data Ethics Office defined a framework that connects privacy, data ethics, and AI governance to BeOne’s RB&S objectives. The phased approach focused on mapping existing privacy indicators to global standards, identifying and validating a limited set of meaningful metrics, and defining a practical implementation roadmap for 2027 and beyond.
Goal
Develop a strategy to align with the United Nations Global Compact’s guidance on human rights by 2025.
2025 Progress
With competing priorities, we were unable to address this goal by the original timeframe. Given the importance of this work, we will continue to work towards this important objective with a goal of completion by 2028.